Intervention

Inhaled Nitric Oxide 0.025 mg/kg IBW/hr delivered via INOpulse DS Device

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions2

Lead sponsors shown1

Clinical trials

1 shown

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)NCT01457781 · 2012-04-01

COMPLETED

Common conditions

Pulmonary Arterial Hypertension1 Pulmonary Hypertension1

Leading sponsors

Bellerophon Pulse Technologies1

Trial status mix

COMPLETED1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.